Transplant ureteric stent insertion reduces the incidence of MUCs, but it is not known whether routine PSRGU is needed to detect unmasked MUCs. This study evaluated whether routine PSRGU in the pRTR is a useful tool to identify MUCs before they become clinically apparent. A retrospective analysis was undertaken of the clinical outcomes following elective stent removal from pediatric kidney‐only transplant recipients at two London centers between 2012 and 2016. Our policy was to perform PSRGU either routinely or urgently if there were concerning symptoms or biochemical evidence of renal allograft dysfunction. Elective stent removal was performed in 86% (97 of 113 pRTR), and 75 (77%) of whom had routine PSRGU at a median (IQR) of 6 (2‐8) days after stent removal. There were changes to management in 3 (4%) of pRTR with PSRGU identifying no MUC. Nineteen patients (25%) had urgent PSRGU, most commonly due to renal allograft dysfunction, at a median (IQR) of 5.5 (2.7‐12.3) days after stent removal. Of these, two pRTR required ureteric intervention. For our current practice of removing transplant stents at 4‐6 weeks post‐transplantation, our study has found no evidence to support routine PSRGU after elective stent removal.
Introduction
Pancreas transplantation is associated with a significant rate of surgical complications, some of which have similar clinical features to acute appendicitis. An incidental appendicectomy (IA) at the time of pancreas transplantation could reduce future diagnostic uncertainty. This study aimed to establish the number of IA undertaken during pancreas transplantation in our unit and examine outcomes. Of those patients that did not undergo an IA, we identified those that subsequently required intervention for their appendix.
Methods
A database of patients who underwent a pancreas transplant in our unit from 01/01/2012 to 10/12/2020 was obtained and patients were followed up until 01/03/2021. Electronic records were examined. Standard statistical analyses were undertaken and death-censored graft survivals were compared using the log-rank test.
Results
243 patients underwent a pancreas transplant. Of the 227 (93%) patients that had not previously had an appendicectomy, 53 (23%) underwent an IA during transplantation. There were no complications and 2 carcinoid tumours were identified. Of the 174 (77%) patients that did not undergo an IA, 3 (2%) patients required subsequent intervention for the appendix. There was no statistically significant difference in operative time (p=0.06), index inpatient length of stay (p=0.50), ICU stay (p=0.80), pancreatic graft survival (p=0.50), or kidney graft survival (p=0.70) between patients who had an IA and those who did not.
Conclusion
IA during pancreas transplantation appears to be safe, and does not significantly prolong pancreas transplantation or adversely affect other outcomes. Surgeons should consider whether incidental appendicectomy should become standard practice.
Take-home message
Appendiceal complications after pancreas transplantation can be challenging and surgeons should consider whether incidental appendicectomy should become standard practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.